Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles A. Baker currently holds 9,000 shares of REGENERON PHARMACEUTICALS INC (REGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles A. Baker has been a net seller of REGN stock. They have purchased $0 and sold $28.3M worth of shares.
Charles A. Baker's most recent insider trade was on Sep 29, 2017, when they sold 2,000 shares at $450.00 per share.
Charles A. Baker serves as Executive at REGENERON PHARMACEUTICALS INC (REGN). They have executed 156 insider transactions totaling $28.3M over their tenure at the company.
Charles A. Baker holds the position of Executive at REGENERON PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Charles A. Baker has shown a selling trading pattern, with $0 in total purchases and $28.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Charles A. Baker was on Mar 24, 2014, when they sold $3.1M worth of REGN shares. This transaction involved 10,200 shares at $300.09 per share.
Charles A. Baker currently owns 9,000 shares of REGENERON PHARMACEUTICALS INC (REGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles A. Baker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles A. Baker has 156 Form 4 filings on record as an insider at REGENERON PHARMACEUTICALS INC.
Set alerts for Charles A. Baker and 40,000+ other insiders.